Company Active LTD

Company profile

Oncolytika Ltd

OncoLytika - HOME

Oncolytika Ltd is a UK company with status active founded in 2010 based in East of England.

CRN
07305115
Founded
2010
Age
15

Overview

Legal name
ONCOLYTIKA LTD
Region
East of England
Registered address
1 THE FIRS
WILBURTON
ELY
CAMBRIDGESHIRE
CB6 3FL
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Apr
2027

Accounts due

Accounts Due

Next accounts due date

07 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jul
2025

Accounts filed

Accounts

Last accounts made up date

23 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

06 Jul
2010

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2014
Funded years
2014, 2017, 2018
Age at first award
4 years

Projects

2018 Feasibility Studies

FAstLyo: Formulation accelerated freeze-drying by reduced vapour flow resistance (micro-collapse)

1 Mar 2018 to 28 Feb 2019

Awarded
£4,935
Total cost £7,050

"New medicines/therapies being developed by the pharmaceutical industry and research organizations are increasingly based on some type of biological (rather than chemical) substance, e.g. a large molecule like a protein rather than a small molecule like aspirin. These substances, known collectively as biopharmaceuticals, are significantly more complex to ...

2017 Collaborative R&D

AtlasBio - Analytical Technologies for the Lyophilization and Stabilization of Biopharmaceuticals

1 Feb 2017 to 31 Jan 2021

Awarded
£47,479
Total cost £67,826

The AtlasBio (Ref. 102610) was conceived in response to the government's Innovate UK funding competition "Analytical Technologies for Biopharmaceuticals". The project aims to develop a multiplexed suite of process analytical technologies (based on Raman, near infrared and impedance spectroscopy) which support the freeze drying of biologics from the scale-...

2014 Collaborative R&D

BioStaRT - Biopharmaceutical Stability at Room Temperature

1 Aug 2014 to 31 Jan 2018

Awarded
£13,328
Total cost £22,212

BioStart aim is to produce lyophilised protein formulations that are stable at room temperature and which reconstitute without compromising product quality (esp. aggregation). Stability at room temperature will extend shelf life and reduce the cold chain costs of refrigerated transportation and storage. Current methods for the development of protein formu...

Product types

Collaborative R&D Feasibility Studies